Market Overview: In 2020, the global market size for pharmaceuticals derived from fish oil exhibited significant strength and is anticipated to maintain a stable Compound Annual Growth Rate (CAGR) in revenue over the forecast period. The growth is propelled by factors such as heightened consumer awareness of the health benefits associated with fish oil, an increase in pharmacy-based companies and applications, and the rapid rise in the incidence of obesity and heart-related disorders.
Fish oil, derived from various fish species, contains essential omega-3 fatty acids, including Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA). The concentration of omega-3 fatty acids in fish oil, sourced from high-oil-content fishes like mackerel, herring, tuna, and salmon, is attributed to its therapeutic effects. These omega-3 fatty acids, which the body does not naturally produce, contribute to pain relief, inflammation reduction, and prevention of blood clotting.
Get a sample copy of the Fish-Oil Based Drug Market report: https://www.reportsanddata.com/download-free-sample/4782
Major Growth Drivers in the Global Fish-Oil Based Drug Market: The primary driver for growth is the abundance of omega-3 fatty acids in fish oil, known to support brain function, reduce the risk of heart disease, arthritis, and asthma. Integrating fish oil into daily functional foods has become a strategic approach for boosting omega-3 consumption, leading many functional food manufacturers to incorporate fish oil into products like pasta, yogurt, and bread. The market is expanding due to the health benefits associated with various fish oils, including anchovy oil, cod oil, menhaden oil, and mackerel oil.
Opportunities for Players in the Global Fish-Oil Based Drug Market: Manufacturers are focusing on advanced production technology to remove environmental pollutants from fish oil, reduce oxidation during manufacturing, and concentrate omega-3 content in finished products. Plant sources like pumpkin seeds, flaxseed oil, walnuts, soybean oil, and canola oil are emerging as potential substitutes for fish oil, with companies exploring sustainable alternatives such as Cargill’s ‘Latitude.’
Global Fish-Oil Based Drug Market Revenue by Product Type Segment: The Docosahexaenoic Acid (DHA) segment is expected to lead in revenue share, driven by its role in reducing bad cholesterol and improving the health of individuals with high blood pressure. Eicosapentaenoic acid (EPA) is anticipated to be the fastest-growing category due to its anti-inflammatory properties, supporting the body’s immune response.
Global Fish-Oil Based Drug Market Revenue by Source Type Segment: Fish oil, primarily derived from anchovy fish, is the most common marine source. However, rising pollutant levels and mercury in fish are expected to impact fish oil prices negatively.
Global Fish-Oil Based Drug Market Leading End-Use Segment: The Pharmaceuticals segment is projected to dominate, driven by the scalp-nourishing effects of fish oil and its use in promoting heart health and dermatology. The infant formula category is expected to grow rapidly due to increased demand for packaged baby nutrition products.
North America Leading in Global Fish-Oil Based Drug Market Revenue: North America holds the largest revenue share, attributed to high product utilization in the pharmaceutical industry, extensive research and development activities, increased consumption of advanced medication, and the growing need to enhance the life expectancy of the aging population.
Asia Pacific Leading in Revenue Compound Annual Growth Rate (CAGR): The Asia Pacific market is forecasted to exhibit the fastest CAGR, driven by heightened consumer awareness of healthy diets, increasing disposable income, growing demand for omega-3 products, and the presence of krill fish farms in the South China Sea and Indian Ocean.
Major Companies Profiled: Key players in the Fish-Oil Based Drug Market include Aker Biomarine Antarctic AS, Orkla Health, BASF SE, Omega Protein Corp., GC Reiber Oils, Lonza, Croda International Plc, EPAX, BioProcess Algae, LLC, Koninklijke DSM N.V., and others. Notable strategies include product innovations, partnerships, and the development of sustainable alternatives.
Detailed Segmentation: The global Fish-Oil Based Drug Market is segmented by product type (Docosahexaenoic acid, Eicosapentaenoic acid, Alpha-linolenic acid), source (Marine Source, Plant Source), application (Supplements and functional foods, Pharmaceuticals, Infants Formula, Animal Feed & Pet Food, Others), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) for the period 2018-2028.
Explore Trending Reports:
Antifungal Drugs Market-https://www.globenewswire.com/news-release/2019/05/13/1822689/0/en/Global-Antifungal-Drugs-Market-To-Reach-USD-13-03-Billion-By-2026-Reports-And-Data.html
Sacral Neuromodulation Market-https://www.globenewswire.com/news-release/2019/06/10/1866396/0/en/Sacral-Neuromodulation-Market-To-Reach-USD-3153-4-Million-By-2026-Reports-And-Data.html
Sterility Testing Market-https://www.globenewswire.com/news-release/2020/02/25/1990365/0/en/Sterility-Testing-Market-To-Reach-USD-1-18-Billion-By-2026-Reports-and-Data.html
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/4782
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release